170 related articles for article (PubMed ID: 15685717)
1. Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes.
Smith CT; Williamson PR; Marson AG
Stat Med; 2005 May; 24(9):1307-19. PubMed ID: 15685717
[TBL] [Abstract][Full Text] [Related]
2. An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes.
Smith CT; Williamson PR; Marson AG
J Eval Clin Pract; 2005 Oct; 11(5):468-78. PubMed ID: 16164588
[TBL] [Abstract][Full Text] [Related]
3. Aggregate data meta-analysis with time-to-event outcomes.
Williamson PR; Smith CT; Hutton JL; Marson AG
Stat Med; 2002 Nov; 21(22):3337-51. PubMed ID: 12407676
[TBL] [Abstract][Full Text] [Related]
4. Investigating trial and treatment heterogeneity in an individual patient data meta-analysis of survival data by means of the penalized maximum likelihood approach.
Rondeau V; Michiels S; Liquet B; Pignon JP
Stat Med; 2008 May; 27(11):1894-910. PubMed ID: 18069745
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of continuous outcomes combining individual patient data and aggregate data.
Riley RD; Lambert PC; Staessen JA; Wang J; Gueyffier F; Thijs L; Boutitie F
Stat Med; 2008 May; 27(11):1870-93. PubMed ID: 18069721
[TBL] [Abstract][Full Text] [Related]
6. Random effects survival models gave a better understanding of heterogeneity in individual patient data meta-analyses.
Michiels S; Baujat B; Mahé C; Sargent DJ; Pignon JP
J Clin Epidemiol; 2005 Mar; 58(3):238-45. PubMed ID: 15718112
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of continuous outcome data from individual patients.
Higgins JP; Whitehead A; Turner RM; Omar RZ; Thompson SG
Stat Med; 2001 Aug; 20(15):2219-41. PubMed ID: 11468761
[TBL] [Abstract][Full Text] [Related]
8. Statistical issues in the assessment of the evidence for an interaction between factors in epilepsy trials.
Williamson PR; Clough HE; Hutton JL; Marson AG; Chadwick DW
Stat Med; 2002 Sep; 21(18):2613-22. PubMed ID: 12228880
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of diagnostic test studies using individual patient data and aggregate data.
Riley RD; Dodd SR; Craig JV; Thompson JR; Williamson PR
Stat Med; 2008 Dec; 27(29):6111-36. PubMed ID: 18816508
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.
Jones AP; Riley RD; Williamson PR; Whitehead A
Clin Trials; 2009 Feb; 6(1):16-27. PubMed ID: 19254930
[TBL] [Abstract][Full Text] [Related]
11. Individual patient-level and study-level meta-analysis for investigating modifiers of treatment effect.
Teramukai S; Matsuyama Y; Mizuno S; Sakamoto J
Jpn J Clin Oncol; 2004 Dec; 34(12):717-21. PubMed ID: 15640501
[TBL] [Abstract][Full Text] [Related]
12. Individual patient meta-analysis of self-monitoring of an oral anticoagulation protocol.
Perera R; Heneghan C; Fitzmaurice D;
J Heart Valve Dis; 2008 Mar; 17(2):233-8. PubMed ID: 18512497
[TBL] [Abstract][Full Text] [Related]
13. Practical methodology of meta-analysis of individual patient data using a survival outcome.
Katsahian S; Latouche A; Mary JY; Chevret S; Porcher R
Contemp Clin Trials; 2008 Mar; 29(2):220-30. PubMed ID: 17884735
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis methodology for combining treatment effects from Cox proportional hazard models with different covariate adjustments.
Yuan X; Anderson SJ
Biom J; 2010 Aug; 52(4):519-37. PubMed ID: 20661952
[TBL] [Abstract][Full Text] [Related]
15. Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors.
Schmid CH; Stark PC; Berlin JA; Landais P; Lau J
J Clin Epidemiol; 2004 Jul; 57(7):683-97. PubMed ID: 15358396
[TBL] [Abstract][Full Text] [Related]
16. Comparison of one-step and two-step meta-analysis models using individual patient data.
Mathew T; Nordström K
Biom J; 2010 Apr; 52(2):271-87. PubMed ID: 20349448
[TBL] [Abstract][Full Text] [Related]
17. Smokers have less reductions in probing depth than non-smokers following nonsurgical periodontal therapy.
Garcia RI
Evid Based Dent; 2005; 6(2):37-8. PubMed ID: 16208387
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.
Dahabreh IJ; Economopoulos K
Clin Trials; 2008; 5(2):116-20. PubMed ID: 18375649
[TBL] [Abstract][Full Text] [Related]
19. Patterns of care, outcomes, and direct health plan costs of antiepileptic therapy: a pharmacoeconomic analysis of the available carbamazepine formulations.
Garnett WR; Gilbert TD; O'Connor P
Clin Ther; 2005 Jul; 27(7):1092-103. PubMed ID: 16154489
[TBL] [Abstract][Full Text] [Related]
20. A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials.
Baujat B; Mahé C; Pignon JP; Hill C
Stat Med; 2002 Sep; 21(18):2641-52. PubMed ID: 12228882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
